Queen Mary, University of London

Medications

Rewiring the biology of leukemia cells to reverse drug resistance

Researchers from Barts Cancer Institute at Queen Mary University of London have identified a way to reverse resistance to a group of cancer drugs, known as kinase inhibitors, in leukemia cells. By rewiring the inner workings ...

Oncology & Cancer

New target for potential blood cancer treatment

Mutations present in a blood cancer known as follicular lymphoma have revealed new molecular targets for potential treatments, according to researchers at Queen Mary University of London (QMUL) together with collaborators ...

Medical research

Largest ever heart stem cell studies get underway

Two linked clinical studies that will show whether stem cell therapy can save the lives of heart attack patients are now underway in London, following the award of €11.7 million funding from the European Commission.

Cardiology

Revolutionary device found to lower blood pressure

A revolutionary device has been shown to significantly lower blood pressure among patients with uncontrolled high blood pressure, compared to those treated with usual drug measures - according to research from Queen Mary ...

Oncology & Cancer

Immunotherapy improves survival in advanced bladder cancer patients

An immunotherapy drug called 'avelumab' has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Queen Mary University ...

page 10 from 40